This session will provide a comprehensive look at the initial implementation of the Drug Supply Chain Security Act (DSCSA) in the U.S. and its impact on serialization practices within the pharmaceutical supply chain, highlighting core functionalities such as aggregation and end-to-end traceability across the U.S. market. In this session, you will learn about how to:
- Facilitate seamless data sharing with major U.S. wholesalers to meet DSCSA standards.
- Overcome challenges in serialization and aggregation with industry-driven strategies.
- Enhance traceability and security across the pharmaceutical supply chain.
- Adapt to evolving DSCSA requirements with best practices for compliance and efficiency.
&nsbp;